Peer Review History
| Original SubmissionAugust 4, 2025 |
|---|
|
Dear Dr. Alzate, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Nov 08 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols . We look forward to receiving your revised manuscript. Kind regards, Petr Heneberg Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. Thank you for stating the following financial disclosure: “This study was funded by Escuela de Microbiología-CODI, Universidad de Antioquia, under grant code 2023-64370.” Please state what role the funders took in the study. If the funders had no role, please state: "The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript." If this statement is not correct you must amend it as needed. Please include this amended Role of Funder statement in your cover letter; we will change the online submission form on your behalf. 3. Please note that your Data Availability Statement is currently missing [the repository name and/or the DOI/accession number of each dataset OR a direct link to access each database]. If your manuscript is accepted for publication, you will be asked to provide these details on a very short timeline. We therefore suggest that you provide this information now, though we will not hold up the peer review process if you are unable. 4. Thank you for stating the following in the Acknowledgments Section of your manuscript: “This study was funded by Escuela de Microbiología-CODI, Universidad de Antioquia, under grant code 2023-64370.” We note that you have provided additional information within the Acknowledgements Section that is not currently declared in your Funding Statement. Please note that funding information should not appear in the Acknowledgments section or other areas of your manuscript. We will only publish funding information present in the Funding Statement section of the online submission form. Please remove any funding-related text from the manuscript and let us know how you would like to update your Funding Statement. Currently, your Funding Statement reads as follows: “This study was funded by Escuela de Microbiología-CODI, Universidad de Antioquia, under grant code 2023-64370” Please include your amended statements within your cover letter; we will change the online submission form on your behalf. 5. We note that there is identifying data in the Supporting Information file <Supp_TABLE_1_NGS_Mic.xlsx>. Due to the inclusion of these potentially identifying data, we have removed this file from your file inventory. Prior to sharing human research participant data, authors should consult with an ethics committee to ensure data are shared in accordance with participant consent and all applicable local laws. Data sharing should never compromise participant privacy. It is therefore not appropriate to publicly share personally identifiable data on human research participants. The following are examples of data that should not be shared: -Name, initials, physical address -Ages more specific than whole numbers -Internet protocol (IP) address -Specific dates (birth dates, death dates, examination dates, etc.) -Contact information such as phone number or email address -Location data -ID numbers that seem specific (long numbers, include initials, titled “Hospital ID”) rather than random (small numbers in numerical order) Data that are not directly identifying may also be inappropriate to share, as in combination they can become identifying. For example, data collected from a small group of participants, vulnerable populations, or private groups should not be shared if they involve indirect identifiers (such as sex, ethnicity, location, etc.) that may risk the identification of study participants. Additional guidance on preparing raw data for publication can be found in our Data Policy (https://journals.plos.org/plosone/s/data-availability#loc-human-research-participant-data-and-other-sensitive-data) and in the following article: http://www.bmj.com/content/340/bmj.c181.long. Please remove or anonymize all personal information (<specific identifying information in file to be removed>), ensure that the data shared are in accordance with participant consent, and re-upload a fully anonymized data set. Please note that spreadsheet columns with personal information must be removed and not hidden as all hidden columns will appear in the published file. 6. If the reviewer comments include a recommendation to cite specific previously published works, please review and evaluate these publications to determine whether they are relevant and should be cited. There is no requirement to cite these works unless the editor has indicated otherwise. Additional Editor Comments: The claim that metataxonomics outperforms microscopy is presented too strongly. The results show that sequencing was superior for detecting Strongyloides and Blastocystis, yet microscopy was more effective for Trichuris and Ascaris. This contrast demonstrates that the performance of each method is parasite dependent. The interpretation should therefore highlight complementarity rather than positioning one method as superior to the other. The treatment of discrepancies between methods is not sufficiently critical. For example, the lack of Giardia detections in sequencing is attributed to true absence in the population, yet microscopy found positive cases. Technical limitations such as primer mismatch or inefficient DNA extraction provide more plausible explanations. Similar issues appear for Iodamoeba and Cyclospora. The manuscript would benefit from a stronger discussion of methodological causes for these mismatches, ideally supported by targeted molecular validation. The sample size of 65 is small and combines specimens from two time periods almost seven years apart. Pooling across such a wide temporal gap introduces the possibility of confounding through epidemiological changes or laboratory practice differences. The authors should address this explicitly and discuss how these potential biases were controlled or accounted for in the study design. Figures showing detection frequencies are presented as simple bar charts without any measure of uncertainty. Although presence and absence data are used, statistical analysis or variability indicators would allow readers to assess the strength of the comparisons. In the phylogenetic analyses, bootstrap values are presented as definitive, yet even high values need careful interpretation. A more cautious discussion of these analyses is necessary. The methods section relies on a single primer pair targeting the 18S V4 region, which has known limitations. The exclusion of cestodes, trematodes, and some amoebae is acknowledged briefly, but the manuscript still describes the method as broad spectrum. A more nuanced description of primer biases and their impact on detection outcomes would improve the study’s credibility. The raw sequencing data are stated to be deposited in the NCBI SRA under BioProject accession PRJNA1293464, with a reviewer link provided. This is an important positive step, and the final version should clearly include accession numbers to ensure compliance with data availability policies and to allow independent verification of results. The discussion emphasizes advantages of sequencing approaches, yet does not sufficiently acknowledge the limitations of this marker or the need for complementary methods. For instance, species level identification of Ascaris is not possible with 18S rDNA, yet the text does not consistently highlight this limitation. Balancing strengths with weaknesses would provide a more rigorous and realistic assessment of the approach. Ethical approval is reported and the use of archived anonymized samples is clearly justified. Consent and confidentiality procedures are explained adequately. However, the quality control procedures for microscopy are not described in detail. Including information on slide reading standards and technician validation would help rule out operator variability as a source of discrepancy. The text is clearly structured and generally readable, yet it often repeats similar arguments and adopts a promotional tone. The writing would benefit from greater conciseness, less redundancy, and a more neutral presentation of the study’s impact. This would align the manuscript more closely with the standards of scientific reporting. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? Reviewer #1: Yes Reviewer #2: Partly ********** 2. Has the statistical analysis been performed appropriately and rigorously? -->?> Reviewer #1: N/A Reviewer #2: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available??> The PLOS Data policy Reviewer #1: Yes Reviewer #2: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #1: Yes Reviewer #2: Yes ********** Reviewer #1: This is an interesting manuscript which describes the use of NGS for identifying parasites in clinical samples, focusing on Blastocystis and Entamoeba spp. The manuscript is well written and follows a logical structure, making it easy for readers to follow the flow of the study. The technical terminology used throughout is appropriate and no major grammatical errors were identified. I felt that the introduction could be expanded to include more recent studies on NGS in parasitology but otherwise provided a good overview of the wider literature within the context of parasitology and molecular diagnostics. The discussion was generally well structured but could benefit from the following minor revisions: 1) There is no mention of sequencing depth and coverage. Was this sufficient to detect low-abundance parasites? Insufficient sequencing depth could lead to under-detection of rare species or mixed infections. The authors should discuss how sequencing variability might influence the results. 2) The potential risk of contamination during sample processing or sequencing is not discussion. This is a common issue in NGS studies, potentially leading to false positives or biased results. 3) How can this be translated to clinical practice? Are the identified parasites clinically significant? What is the practicality of implementation in routine clinical/ field settings? 4) Discuss any recent studies on NGS applications in parasitology (if any). Include a more critical comparison of NGS with other emerging diagnostic technologies. Reviewer #2: Intestinal parasites cause a major health burden worldwide, and traditional microscopy offers only limited sensitivity. In this manuscript, the authors applied an NGS-based metataxonomic approach, which showed higher sensitivity than microscopy for Strongyloides stercoralis but lower for Trichuris trichiura. The method also provided improved species- and subtype-level resolution. Overall, metataxonomics appears powerful for broad parasite detection, although primer design still requires refinement. I find this topic very interesting, but I have a few questions and suggestions to consider: Major comments: 1. It is unclear whether random primers were used for library construction and sequencing, or whether DNA extraction was followed by library preparation employing only the 18S-V4Fw and 18S-V4 primers. An alternative possibility is that these primers were used specifically as supplements for sequencing. Clarification of this methodological step would be very helpful. 2. NGS is undoubtedly a powerful tool for species identification, but it also has the issue of noisy sequencing reads. The main concern here is that the ground truth of this study is not clearly defined, making it difficult to evaluate what are false positives or false negatives (e.g., lines 245–248) and how these were ruled out. In turns, it becomes challenging to assess which method truly outperforms the others. 3. The authors suggest that the failure of the NGS-based metataxonomic approach for Trichuris trichiura detection may be due to the high resistance of the eggshell, which leads to the issue of DNA isolation and lower yield. This hypothesis could be easily tested by using a bioanalyzer or Qubit to precisely quantify the amount and quality of DNA. Minor comments: 1. There are quite a number of typos, which require careful correction 2. I also suggest that the authors improve the organization of their result figures and captions related to the phylogenetic analyses. (e.g., what the numbers represent? what the distinction is between “GE_Strongyloides_stercoralis_” and “Strongyloides_stercoralis” within the same phylogenetic tree??). In its current form, these figures are somewhat difficult to interpret. ********** what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy Reviewer #1: No Reviewer #2: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org . Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
Dear Dr. Alzate, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Dec 17 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.
If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols . We look forward to receiving your revised manuscript. Kind regards, Petr Heneberg Academic Editor PLOS ONE Journal Requirements: 1. If the reviewer comments include a recommendation to cite specific previously published works, please review and evaluate these publications to determine whether they are relevant and should be cited. There is no requirement to cite these works unless the editor has indicated otherwise. 2. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. Additional Editor Comments: The revision substantially improved the paper. I have just one minor comment - the manuscript would benefit from a stronger emphasis on One Health and zoonotic perspectives, framing intestinal parasite detection within the broader context of human–animal–environment interactions. Incorporating a One Health viewpoint aligns the study with current global efforts to understand and mitigate cross-species transmission risks through integrated diagnostic and surveillance strategies. For instance, One Health (18, 2024, 100679) discusses how the control of companion animal parasites directly influences human health outcomes and advocates for coordinated One Health approaches to reduce zoonotic burdens. Similarly, Philosophical Transactions of the Royal Society B (379, 2023, 20220445) reviews the debated zoonotic potential of Strongyloides infections transmitted between dogs and humans, underscoring the clinical and epidemiological importance of molecular differentiation across hosts. A global synthesis published in PLOS Global Public Health (5, 2025, e0004614) examines cross-host soil-transmitted helminth infections in humans and domestic or livestock animals, highlighting that many intestinal parasites circulate within multi-host ecological systems rather than exclusively human reservoirs. In addition, Review One Health (21, 2025, 101166) presents recent evidence for bidirectional transmission of Blastocystis between pets and their owners and calls for standardized genomic approaches to discern true zoonotic events from shared environmental exposures. Integrating insights from these studies would allow to position metataxonomic diagnostics not merely as a technical advancement but as a practical One Health surveillance tool capable of mapping host–parasite networks, detecting emerging zoonoses, and informing cross-sectoral control strategies linking human, veterinary, and environmental health. [Note: HTML markup is below. Please do not edit.] [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] To ensure your figures meet our technical requirements, please review our figure guidelines: https://journals.plos.org/plosone/s/figures You may also use PLOS’s free figure tool, NAAS, to help you prepare publication quality figures: https://journals.plos.org/plosone/s/figures#loc-tools-for-figure-preparation. NAAS will assess whether your figures meet our technical requirements by comparing each figure against our figure specifications. |
| Revision 2 |
|
Dear Dr. Alzate, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Dec 24 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols . We look forward to receiving your revised manuscript. Kind regards, Petr Heneberg Academic Editor PLOS ONE Journal Requirements: If the reviewer comments include a recommendation to cite specific previously published works, please review and evaluate these publications to determine whether they are relevant and should be cited. There is no requirement to cite these works unless the editor has indicated otherwise. Additional Editor Comments: The references need to be double-checked, unnecessary Spanish words removed, and missing letters added. The suggested text was added, but it contains some weird references instead of the suggested ones. The reference on Strongyloides was replaced by some irrelevant one; similarly, the reference on Blastocystis was replaced by a paper that only marginally deals with Blastocystis itself. Remove the text likely generated by LLM (the presence of em-dashes, and unnecessary words, such as “Finally”, etc., and unusual words, such as “plausible” suggests use some AI-generated text). Add a real discussion of your results. Include a Statistics section and analyze your data using relevant statistical methods. [Note: HTML markup is below. Please do not edit.] [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] To ensure your figures meet our technical requirements, please review our figure guidelines: https://journals.plos.org/plosone/s/figures You may also use PLOS’s free figure tool, NAAS, to help you prepare publication quality figures: https://journals.plos.org/plosone/s/figures#loc-tools-for-figure-preparation. NAAS will assess whether your figures meet our technical requirements by comparing each figure against our figure specifications. |
| Revision 3 |
|
Next-Gen Intestinal Parasite Detection: Leveraging Metataxonomics for Improved Diagnosis of Intestinal Protists and Helminths PONE-D-25-39373R3 Dear Dr. Alzate, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. For questions related to billing, please contact billing support . If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Petr Heneberg Academic Editor PLOS One Additional Editor Comments (optional): Reviewers' comments: |
| Formally Accepted |
|
PONE-D-25-39373R3 PLOS One Dear Dr. Alzate, I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS One. Congratulations! Your manuscript is now being handed over to our production team. At this stage, our production department will prepare your paper for publication. This includes ensuring the following: * All references, tables, and figures are properly cited * All relevant supporting information is included in the manuscript submission, * There are no issues that prevent the paper from being properly typeset You will receive further instructions from the production team, including instructions on how to review your proof when it is ready. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few days to review your paper and let you know the next and final steps. Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. You will receive an invoice from PLOS for your publication fee after your manuscript has reached the completed accept phase. If you receive an email requesting payment before acceptance or for any other service, this may be a phishing scheme. Learn how to identify phishing emails and protect your accounts at https://explore.plos.org/phishing. If we can help with anything else, please email us at customercare@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Petr Heneberg Academic Editor PLOS One |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .